Leukemia inhibitory factor involvement in human ulcerative colitis and its potential role in malignant course

European Cytokine Network

Volumn 9, Issue 4, 1998, Pages 607-612

  Guimbaud, Rosine ^a   Abitbol, Vered ^a   Bertrand, Viviane ^a   Quartier, Gilles ^a   Chauvelot Moachon, Laurence ^b   Giroud, Jean Paul ^b   Couturier, Daniel ^a   Chaussade, Stanislas ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CNRS   (France)

^c NONE   (France)

Author keywords

Colon carcinoma; HT29; IL 8; LIF; Tumor growth; Ulcerative colitis

Indexed keywords

ACUTE PHASE PROTEIN; CHEMOKINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; MESALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CANCER CELL CULTURE; CELL STRAIN CACO 2; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MACROPHAGE; MALE; NEUTROPHIL; PROTEIN SYNTHESIS; TUMOR GROWTH; ULCERATIVE COLITIS;

EID: 0032424595     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Godard A, Gascan H, Naulet J, Peyrat M A, Jacques Y, Soulillou J P, Moreau J F. 1988. Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood 71: 1618.
2. Gascan H, Anegyon I, Praloran V, Naulet J, Godard A, Soulillou J P, Jacques Y. 1990. Constitutive production of human interleukin for DA cells/leukemia inhibitory factor by human tumor cell lines derived from various tissues. J. Immunol. 144: 2592.
3. Kurzrock R, Estrov Z, Wetzler M, Gutterman J U, Talpaz M, 1991. LIF: not just a leukemia inhibitory factor. (Review) Endocr. Rev. 12: 208.
4. Godard A, Heymann D, Raher S, Anegon I, Peyrat M A, Le Mauff B, Mouray E, Gregoire M, Virdee K, Soulillou J P, Moreau J F, Jacques Y. 1992. High and low affinity receptors for human interleukin for DA cells/LIF on human cells. Molecular characterization and cellular distribution. J. Biol. Chem. 267: 3214.
5. Metcalf D. 1991. The leukemia inhibitory factor (LIF). (Review) Int. J. Cell Cloning 9: 95.
6. Waring P M, Carroll G J, Kandiah D A, Buirski G, Metcalf D, 1993. Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 36: 911.
7. Bruce A G, Linsley P S, Rose T M. 1992. Oncostatin M. (Review) Prog. Growth Factor Res. 4: 157.
8. Gearing D P. 1993. Leukemia inhibitory factor and its receptor. (Review) Adv. Immunol. 53: 31.
9. Jansen P M, De Jong I W, Hart M, Kim K J, Aarden L A, Hinshaw L B, Taylor F B Jr, Hack C E. 1996. Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-α. J. Immunol. 156: 4401.
10. Villiers D, Dao T, Nguyen J M, Bironneau E, Godard A, Moreau M, De Groote D, Nicolas F, Soulillou J P, Anegon I. 1995. Increased plasma levels of human interleukin for DA1 a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis. J. Infect. Dis. 171: 232.
11. Lecron J C, Roblot P, Chevalier S, Morel F, Alderman E, Gombert J, Gascan H. 1993. High circulating leukemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under corticosteroid therapy. Clin. Exp. Immunol. 92: 23.
12. Dechanet J, Taupin J L, Chomarat P, Rissoan M C, Moreau J F, Bauchereau J, Miossec P. 1994. Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur. J. Immunol. 24: 3222.
13. Lotz M, Moats T, Villiger P M. 1992. Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathegenesis of arthritis. J. Clin. Invest. 90: 888.
14. Waring P, Wycherley K, Cary D, Nicola N, Metcalf D. 1992. Leukemia inhibitory factor levels are elevated in septic shock and various body fluids. J. Clin. Invest. 90: 2031.
15. Isaacs K L, Sartor R B, Haskill S. 1992. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 103: 1587.
16. Greenstein A J, Sachar D B, Smith H, Pucillo A, Papatesta A E, Kreel I, Geller S A, Janowitz H D, Aufses A H. 1979. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 77: 290.
17. Ekbom A, Helmick C, Zack M, Adami H O. 1990. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 336: 357.
18. Choi P M, Zelig M P. 1994. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35: 950.
19. Eastwood G L. 1995. A review of gastrointestinal epithelial renewal and its relevance to the development of adenocarcinomas of the gastrointestinal tract. (Review) J. Clin. Gastroenterol. 21 (suppl. 1): S1.
20. Creasia D, Nettesheim P. 1974. Particulars and chronic inflammation increase rates of carcinogenesis. In: Experimental lung cancer, eds. Karbe E, Park J. Springer Verlag, New York: 234.
21. Alexander-Williams J. 1976. Inflammatory disease of the bowel. Colon Rectum 19: 579.
22. Argyris T, Slaga T. 1981. Promotion of carcinomas by repeat abrasion in initiated skin of mice. Cancer Res. 41: 5193.
23. Cerutti PA, Trump BF. 1991. Inflammation and oxidative stress in carcinogenesis. (Review) Cancer Cells 3: 1.
24. Alexander R J, Panja A, Kaplan-Liss E, Mayer L, Raicht R F. 1995. Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease. Dig. Dis. Sci. 40: 485.
25. Burg C, Patry Y, Le Pendu J, Moreau M, Tesson L, Godard A, Soulillou J P, Meflah K, Anegon I. 1995. Leukemia inhibitory factor derived from rat colon carcinoma cells increases host susceptibility to tumor growth. Cytokine 7: 784.
26. Heymann D, Godard A, Raher S, Ringeard S, Lassort D, Blanchard F, Harb J. 1995. Human interleukin for DA cells/leukemia inhibitory factor and oncostatin M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form. Cytokine 7: 111.
27. Raab Y, Hällgren R, Knutson L, Krog M, Gerdin B. 1992. A technique for segmental rectal and colonic perfusion in humans. Am. J. Gastroenterol. 87: 1453.
28. Guimbaud R, Izzo A, Martinolle P, Vidon N, Couturier D, Benveniste J, Chaussade S. 1995. Intraluminal excretion of PAF, lysoPAF and acetylhydrolase in patients with ulcerative colitis. Dig. Dis. Sci. 40: 2635.
29. Blottière H M, Zennadi R, Gregoire M, Aillet G, Denis M G, Meflah K, Le Pendu J. 1993. Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells. Int. J. Cancer 53: 409.
30. Anegon I, Moreau M, Godard A, Jacques Y, Peyrat M A, Hallet M M, Wong G, Soulillou J P. 1990. Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes. Cell Immunol. 130: 50.
31. Brown M A, Metcalf D, Gough N M. 1994. Leukemia inhibitory factor and IL-6 are expressed at very low levels in the normal adult mouse and are induced by inflammation. Cytokine 6: 300.
32. Miyagi T, Akashi M, Yamato K, Miyoshi I, Koeffler H P. 1991. D-faclor: modulation of expression in fibroblasts. Leukemia Res. 15: 441.
33. Hilton D J, Nicola N A, Waring P M, Metcalf D. 1991. Clearance and fate of leukemia inhibitory factor (LIF) after injection into mice. J. Cell Physiol. 148: 430.
34. Guimbaud R, Chauvelot-Moachon L, Giroud J P, Couturier D, Chaussade S. 1995. Ulcerative colitis is an outstanding disease for the number and extent of inflammatory cytokines locally produced. Gastroentorology 108: A829.
35. Villiger P M, Geng Y, Lotz M. 1993. Induction of cytokine expression by leukemia inhibitory factor. J. Clin. Invest. 91: 1575.
36. Opdenakker G, Van Damme J. 1992. Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol. Today 13: 463.
37. Opdenakker G, Van Damme J. 1992. Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. (Review) Cytokine 4: 251.
38. Kajimura N, Iseki H, Tanaka R, Ohue C, Otsubo K, Gyoutoku M, Sasaki K, Akiyama Y, Yamaguchi K. 1996. Toxohormones responsible for cancer cachexia syndrome in nude mice bearing human cancer cell lines. Cancer Chemother. Pharmacol. 38 (suppl.): S48.